Avidity Partners Management LP Q4 2023 Filing
Filed February 14, 2024
Portfolio Value
$2.7T
Holdings
73
Report Date
Q4 2023
Filing Type
13F-HR
All Holdings (73 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ARVNARVINAS INC | 2,985,117 | $122.9B | 4.48% | |
| 2 | BSXBOSTON SCIENTIFIC CORP | 1,890,000 | $109.3B | 3.98% | |
| 3 | CITHE CIGNA GROUP | 350,000 | $104.8B | 3.82% | Call |
| 4 | TMOTHERMO FISHER SCIENTIFIC INC | 182,600 | $96.9B | 3.53% | |
| 5 | ACHCACADIA HEALTHCARE COMPANY IN | 1,156,692 | $89.9B | 3.28% | |
| 6 | NBIXNEUROCRINE BIOSCIENCES INC | 658,000 | $86.7B | 3.16% | |
| 7 | SNDXSYNDAX PHARMACEUTICALS INC | 3,950,000 | $85.4B | 3.11% | |
| 8 | NTRANATERA INC | 1,110,000 | $69.5B | 2.53% | |
| 9 | GPCRSTRUCTURE THERAPEUTICS INC | 1,680,000 | $68.5B | 2.50% | Call |
| 10 | DHRDANAHER CORPORATION | 290,000 | $67.1B | 2.44% | |
| 11 | THCTENET HEALTHCARE CORP | 871,000 | $65.8B | 2.40% | |
| 12 | KRTXKARUNA THERAPEUTICS INC | 206,000 | $65.2B | 2.38% | |
| 13 | —FUSION PHARMACEUTICALS INC | 6,500,328 | $62.5B | 2.28% | |
| 14 | JAZZJAZZ PHARMACEUTICALS PLC | 489,119 | $60.2B | 2.19% | |
| 15 | REGNREGENERON PHARMACEUTICALS | 68,000 | $59.7B | 2.18% | |
| 16 | CVSCVS HEALTH CORP | 740,000 | $58.4B | 2.13% | |
| 17 | 2L9BLUEPRINT MEDICINES CORP | 615,000 | $56.7B | 2.07% | |
| 18 | IMGNEURIMMUNOGEN INC | 1,829,215 | $54.2B | 1.98% | |
| 19 | IDYAIDEAYA BIOSCIENCES INC | 1,520,000 | $54.1B | 1.97% | |
| 20 | UTHUNITED THERAPEUTICS CORP DEL | 237,202 | $52.2B | 1.90% | |
| 21 | RCKTROCKET PHARMACEUTICALS INC | 1,719,103 | $51.5B | 1.88% | |
| 22 | ITCIEURINTRA-CELLULAR THERAPIES INC | 710,000 | $50.9B | 1.85% | |
| 23 | LLYELI LILLY & CO | 85,000 | $49.5B | 1.81% | |
| 24 | BHVNBIOHAVEN LTD | 1,148,308 | $49.1B | 1.79% | |
| 25 | AVTRAVANTOR INC | 2,121,844 | $48.4B | 1.77% | |
| 26 | ZTSZOETIS INC | 240,000 | $47.4B | 1.73% | |
| 27 | HUMHUMANA INC | 100,000 | $45.8B | 1.67% | |
| 28 | ABBVABBVIE INC | 284,405 | $44.1B | 1.61% | |
| 29 | AFWALIGN TECHNOLOGY INC | 155,800 | $42.7B | 1.56% | |
| 30 | LEGNLEGEND BIOTECH CORP | 685,000 | $41.2B | 1.50% | |
| 31 | BDXBECTON DICKINSON & CO | 165,706 | $40.4B | 1.47% | |
| 32 | RAREULTRAGENYX PHARMACEUTICAL IN | 844,500 | $40.4B | 1.47% | |
| 33 | MCKMCKESSON CORP | 85,500 | $39.6B | 1.44% | |
| 34 | XENEXENON PHARMACEUTICALS INC | 815,993 | $37.6B | 1.37% | |
| 35 | SGRYSURGERY PARTNERS INC | 1,165,932 | $37.3B | 1.36% | |
| 36 | AXSMAXSOME THERAPEUTICS INC | 459,400 | $36.6B | 1.33% | |
| 37 | CRBUCARIBOU BIOSCIENCES INC | 6,360,212 | $36.4B | 1.33% | |
| 38 | PCVXVAXCYTE INC | 570,137 | $35.8B | 1.30% | |
| 39 | NMRANEUMORA THERAPEUTICS INC. | 1,990,632 | $33.9B | 1.24% | |
| 40 | MIRMMIRUM PHARMACEUTICALS INC | 1,142,850 | $33.7B | 1.23% | |
| 41 | UNHUNITEDHEALTH GROUP INC | 58,500 | $30.8B | 1.12% | |
| 42 | PRVAPRIVIA HEALTH GROUP INC | 1,287,000 | $29.6B | 1.08% | |
| 43 | ISRGINTUITIVE SURGICAL INC | 85,000 | $28.7B | 1.05% | |
| 44 | LNTHLANTHEUS HLDGS INC | 380,000 | $23.6B | 0.86% | |
| 45 | ANTXAN2 THERAPEUTICS INC | 1,140,000 | $23.4B | 0.85% | |
| 46 | ACIUAC IMMUNE SA | 4,469,080 | $22.3B | 0.81% | |
| 47 | ARWRARROWHEAD PHARMACEUTICALS IN | 714,000 | $21.8B | 0.80% | |
| 48 | IMCRIMMUNOCORE HLDGS PLC | 300,200 | $20.5B | 0.75% | |
| 49 | CRNXCRINETICS PHARMACEUTICALS IN | 529,000 | $18.8B | 0.69% | |
| 50 | PHATPHATHOM PHARMACEUTICALS INC | 1,721,580 | $15.7B | 0.57% | |
| 51 | VRNAVERONA PHARMA PLC | 780,900 | $15.5B | 0.57% | |
| 52 | IMNMIMMUNOME INC | 1,333,479 | $14.3B | 0.52% | |
| 53 | AG8AGILENT TECHNOLOGIES INC | 99,000 | $13.8B | 0.50% | |
| 54 | NTLAINTELLIA THERAPEUTICS INC | 447,434 | $13.6B | 0.50% | |
| 55 | SYRSSYROS PHARMACEUTICALS INC | 1,673,538 | $13.0B | 0.48% | |
| 56 | DNTHDIANTHUS THERAPEUTICS INC | 1,217,554 | $12.7B | 0.46% | |
| 57 | ARGXARGENX SE | 31,000 | $11.8B | 0.43% | |
| 58 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 276,888 | $11.7B | 0.43% | |
| 59 | COLLCOLLEGIUM PHARMACEUTICAL INC | 361,363 | $11.1B | 0.41% | |
| 60 | IMVTIMMUNOVANT INC | 245,000 | $10.3B | 0.38% | |
| 61 | NGNENEUROGENE INC | 466,243 | $9.0B | 0.33% | |
| 62 | TVTXTRAVERE THERAPEUTICS INC | 827,010 | $7.4B | 0.27% | |
| 63 | KPTIEURKARYOPHARM THERAPEUTICS INC | 8,298,570 | $7.2B | 0.26% | |
| 64 | AKROAKERO THERAPEUTICS INC | 235,000 | $5.5B | 0.20% | |
| 65 | KZRKEZAR LIFE SCIENCES INC | 5,025,454 | $4.8B | 0.17% | |
| 66 | IPSCCENTURY THERAPEUTICS INC | 1,355,000 | $4.5B | 0.16% | |
| 67 | SCYXSCYNEXIS INC | 1,448,728 | $3.2B | 0.12% | |
| 68 | CMPXCOMPASS THERAPEUTICS INC | 1,599,600 | $2.5B | 0.09% | |
| 69 | RVMDREVOLUTION MEDICINES INC | 60,000 | $1.7B | 0.06% | |
| 70 | HYPRHYPERFINE INC | 1,188,178 | $1.3B | 0.05% | |
| 71 | AMLXAMYLYX PHARMACEUTICALS INC | 64,501 | $949.5M | 0.03% | |
| 72 | —CAREMAX INC | 636,000 | $316.9M | 0.01% | |
| 73 | NUVB/WSNUVATION BIO INC | 89,543 | $5.4M | 0.00% |